Results 21 to 30 of about 20,646 (210)

Letrozole-induced endometrial preparation improved the pregnancy outcomes after frozen blastocyst transfer compared to the natural cycle: a retrospective cohort study

open access: yesBMC Pregnancy and Childbirth, 2022
Background Letrozole treatment is considered an effective option in endometrial preparation for frozen embryo transfers in patients with ovulation disorders or irregular menstruation; however, the effectiveness of letrozole-induced endometrial ...
Kenji Ezoe   +4 more
doaj   +1 more source

Letrozole-loaded nonionic surfactant vesicles prepared via a slurry-based proniosome technology: Formulation development and characterization [PDF]

open access: yes, 2020
Slurry-based Letrozole (LTZ)-loaded proniosomes were designed using sucrose or sorbitol as carriers and various ratios of cholesterol (CH) and Tween 80 (T80) as lipid composition.
Khudair, Nada   +11 more
core   +1 more source

Comparison of Treatment Outcomes of Infertile Women by Clomiphene Citrate and Letrozole with Gonadotropins Underwent Intrauterine Insemination [PDF]

open access: yesActa Medica Iranica, 2012
This study was designed to compare the effect of clomiphene and letrozole in ovulatory stimulation in infertile women under intrauterine insemination who referred to Mahdiyeh infertility clinic during 2008-2009.
Shahrzad Zadehmodares   +4 more
doaj   +1 more source

Letrozole plus misoprostol versus misoprostol alone in the induction of anembryonic missed abortion: a randomized controlled trial conducted in Upper Egypt

open access: yesMiddle East Fertility Society Journal, 2023
Background A missed abortion is a spontaneous abortion in which the embryo or fetus has already died but has remained in the uterus for days or weeks with a closed cervical ostium.
Ramy Heshmat Zekry Tadros   +3 more
doaj   +1 more source

Impact of 2.5 mg versus 5 mg letrozole co-treatment in an antagonist protocol for IVF: a retrospective study

open access: yesFrontiers in Endocrinology, 2023
ObjectiveThe present study aimed to compare the effectiveness of two different doses of letrozole (2.5 mg and 5 mg daily) in an antagonist protocol for infertile women with normal ovarian reserve.MethodsThis retrospective cohort study included infertile ...
Jing Lin   +6 more
doaj   +1 more source

Global expression response of genes in sex-undifferentiated Nile tilapia gonads after exposure to trace letrozole

open access: yesEcotoxicology and Environmental Safety, 2021
The aromatase inhibitor letrozole can be found in rivers, effluents, and even drinking water. Studies have demonstrated that letrozole affects various metabolic pathways and may cause reproductive toxicity, especially in fish exposed during development ...
Jian Teng   +4 more
doaj   +1 more source

Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer

open access: yesTherapeutic Advances in Medical Oncology, 2023
Background: Current standard-of-care first-line treatment of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer (ABC) is cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + endocrine
Komal Jhaveri   +9 more
doaj   +1 more source

Anything Rare is Possible: Letrozole Induced Eczematous Skin Eruption [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Letrozole is used as first line drug in postmenopausal women with early-stage or advanced hormone-sensitive breast cancer. Letrozole has favourable tolerability profile when administered once daily and significant adverse reactions occur rarely.
Amruta Tripathy   +4 more
doaj   +1 more source

Coenzyme q10 and letrozole versus letrozole alone for ovulation induction in polycystic ovary syndrome

open access: yes, 2022
Background: Polycystic ovary syndrome (PCOS) is the largest single cause of anovulatory infertility. PCOS is associated with oxidative stress. Coenzyme q10 (Coq10) is an antioxidant that protects the mitochondria from damage caused by either insulin ...
Halder, Suravi   +5 more
core   +1 more source

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers [PDF]

open access: yes, 2013
Introduction: We examined if a combination of proliferation markers and estrogen receptor (ER) activity could predict early versus late relapses in ER-positive breast cancer and inform the choice and length of adjuvant endocrine therapy.
Luca Gianni   +39 more
core   +1 more source

Home - About - Disclaimer - Privacy